Moffitt Presentations at SITC 2024
Note - all times are listed as CST
-
Wednesday, November 6, 2024
TIL Therapy for Pediatric Cancers and Sarcomas
Workshop Oral
John Mullinax
Shari Pilon-Thomas
11:50am - 12:10pm
Grand Ballroom B -
Thursday, November 7, 2024
16: Engineering a chemokine/cytokine-releasing biopolymer scaffold to induce tertiary lymphoid-like structures
Workshop Oral
Rana Falahat
Time TBA: Workshop is 9am - 5pm
Grand Ballroom AB61: Insights into interferons (IFN)-myeloid cell crosstalk: An analysis of E3611 testing ipilimumab alone or in combination with IFN-α in advanced melanoma
Workshop Poster
Ahmad Tarhini
3:10 - 5pm
Grand Ballroom AB137: Tertiary Lymphoid Structure Signature in Digital H&E Slides as a Prognostic Biomarker in Cutaneous Melanoma
Workshop Poster
Xuefeng Wang
3:10 - 5pm
Grand Ballroom AB291: C-terminus CD28 phosphorylation modulates IL-2 secretion and antitumor effect of CAR-T cells, in a preclinical model of pancreatic cancer
Workshop Poster
Elena Martinez Planes
3:10 - 5pm
Grand Ballroom AB450: Pooled analysis of efficacy outcomes from early-phase trials of tumor infiltrating lymphocyte therapy in advanced melanoma
Workshop Poster
Lilit Karapetyan
3:10 - 5pm
Grand Ballroom AB451: CD40L-4-1BB can stimulate tumor infiltrating lymphocyte ex vivo expansion from melanoma core biopsies
Workshop Poster
Lilit Karapetyan
3:10 - 5pm
Grand Ballroom AB636: A phase 1 trial of CUE-102, a novel WT1-pHLA-IL2-Fc T cell engager in HLA-A*0201 positive patients with WT1-positive recurrent/metastatic cancers
Workshop Poster
Dae Won Kim
3:10 - 5pm
Grand Ballroom AB639: Phase I clinical trial of autologous gamma/delta-enriched chimeric antigen receptor (CAR)-T cells to target prostate stem cell antigen (PSCA) in patients with bone metastatic prostate cancer
Workshop Poster
Daniel Abate-Daga
3:10 - 5pm
Grand Ballroom AB649: A phase 1 dose-escalation and expansion study of CUE-101 as monotherapy and in combination with pembrolizumab in patients with recurrent/metastatic HPV16+ head and neck squamous cell cancer
Workshop Poster
Christine Chung
3:10 - 5pm
Grand Ballroom AB1138: Engineering 3D living systems with in situ high resolution imaging to capture the dynamics of cancer immunotherapy
Workshop Poster
Greg Sawyer
3:10 - 5pm
Grand Ballroom AB1369: Engineering approaches to exploit MHC-II presentation on lung cancer cells
Workshop Poster
Alex Jaeger
3:10 - 5pm
Grand Ballroom AB -
Friday, November 8, 2024
29: Associations of somatic mutations and other genetic alterations with survival outcome following CTLA4 blockade in melanoma patients
Poster
Ahmad Tarhini
9am - 7pm
Grand Ballroom AB61: Insights into interferons (IFN)-myeloid cell crosstalk: An analysis of E3611 testing ipilimumab alone or in combination with IFN-α in advanced melanoma
Poster
Ahmad Tarhini
9am - 7pm
Grand Ballroom AB67: A 12-chemokine gene expression signature identifies melanomas with heightened tumor infiltrating lymphocytes: A retrospective analysis
Poster
Daniel Abate-Daga
9am - 7pm
Grand Ballroom AB137: Tertiary Lymphoid Structure Signature in Digital H&E Slides as a Prognostic Biomarker in Cutaneous Melanoma
Listed as Top 100 abstract
Poster
Xuefeng Wang
9am - 7pm
Grand Ballroom AB291: C-terminus CD28 phosphorylation modulates IL-2 secretion and antitumor effect of CAR-T cells, in a preclinical model of pancreatic cancer
Poster
Elena Martinez Planes
9am - 7pm
Grand Ballroom AB411: Intrathecal (IT) delivery of peptide-pulsed dendritic cell (cDC1) vaccine is highly efficacious for the treatment of breast cancer-associated leptomeningeal disease (LMD) in preclinical models
Poster
Peter Forsyth
9am - 7pm
Grand Ballroom AB445: Analysis and Feasibility of Cerebrospinal Fluid (CSF) Lymphocyte Expansion from Patients with Melanoma Leptomeningeal Disease (M-LMD)
Poster
Michael Carter
9am - 7pm
Grand Ballroom AB451: CD40L-4-1BB can stimulate tumor infiltrating lymphocyte ex vivo expansion from melanoma core biopsies
Poster
Lilit Karapetyan
9am - 7pm
Grand Ballroom AB461: Leveraging tumor infiltrating B-cells to enhance TIL immunotherapy using CD40 and 41BB agonism
Poster
Renata Rossetti
9am - 7pm
Grand Ballroom AB633: A Phase 1, Open-Label, Multicenter Study to Assess the Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors
Poster
Tiago Biachi de Castria
9am - 7pm
Grand Ballroom AB639: Phase I clinical trial of autologous gamma/delta-enriched chimeric antigen receptor (CAR)-T cells to target prostate stem cell antigen (PSCA) in patients with bone metastatic prostate cancer
Poster
Daniel Abate-Daga
9am - 7pm
Grand Ballroom AB853: Effect of Transdermal bicarbonate buffer therapy on tumor acidity and CD8 T cell responses in bladder cancer
Poster
Oluwaseyi Oluwatola
9am - 7pm
Grand Ballroom AB887: The Chromosome 19 MicroRNA Cluster Facilitates TIL-Based Immune Evasion in Human Melanoma
Poster
Marian Smallin
9am - 7pm
Grand Ballroom AB1363: Evaluation of a Novel Merkel Cell Carcinoma Mouse Model and Response to Anti-PD-1 Immunotherapy
Poster
Karol Prieto
9am - 7pm
Grand Ballroom AB649: A phase 1 dose-escalation and expansion study of CUE-101 as monotherapy and in combination with pembrolizumab in patients with recurrent/metastatic HPV16+ head and neck squamous cell cancer
Listed as Top 100 abstract
Poster
Christine Chung
Grand Ballroom AB1369: Engineering approaches to exploit MHC-II presentation on lung cancer cells
Listed as Top 100 abstract
Oral
Alex Jaeger
Grand Ballroom AB -
Saturday, November 9, 2024
16: Engineering a chemokine/cytokine-releasing biopolymer scaffold to induce tertiary lymphoid-like structures
Poster
Rana Falahat
9am - 8:30pm
Grand Ballroom AB448: Defining the tumor-infiltrating lymphocyte antigenic landscape in head and neck cancer
Poster
MacLean Hall
9am - 8:30pm
Grand Ballroom AB450: Pooled analysis of efficacy outcomes from early-phase trials of tumor infiltrating lymphocyte therapy in advanced melanoma
Listed as Top 100 abstract
Poster
Lilit Karapetyan
9am - 8:30pm
Grand Ballroom AB460: Enrichment of neoantigen reactive tumor infiltrating lymphocytes (TIL) in gastric cancer
Poster
Madeline Rodriguez Valentin
9am - 8:30pm
Grand Ballroom AB630: A first-in-human phase 1 trial of intrathecal (IT) dendritic cells (cDC1s) against HER2/HER3 in patients with leptomeningeal disease (LMD) from triple-negative (TNBC) or HER2+ breast cancer (BC)
Poster
Peter Forsyth
9am - 8:30pm
Grand Ballroom AB636: A phase 1 trial of CUE-102, a novel WT1-pHLA-IL2-Fc T cell engager in HLA-A*0201 positive patients with WT1-positive recurrent/metastatic cancers
Poster
Dae Won Kim
9am - 8:30pm
Grand Ballroom AB916: Utilizing spectral flow cytometry for deep memory phenotyping of tumor infiltrating lymphocyte products
Poster
Mitchell Braun
9am - 8:30pm
Grand Ballroom AB982: Pharmacologic Oncogene Pathway Agonism to Sensitize RAS-Mutant Cancers to Immunotherapy
Poster
Kenneth Tsai
9am - 8:30pm
Grand Ballroom AB1102: Engineering cellular backpacks to deliver therapies to “undruggable” p53 in lung cancer
Poster
Elsa Flores
9am - 8:30pm
Grand Ballroom AB1138: Engineering 3D living systems with in situ high resolution imaging to capture the dynamics of cancer immunotherapy
Listed as Top 100 abstract
Poster
Greg Sawyer
9am - 8:30pm
Grand Ballroom AB596: Oncolytic virotherapy combined with Nivolumab elicits complete responses in muscle-invasive bladder cancer in association with the formation of tertiary lymphoid structures
Listed as Top 100 abstract
Oral
Roger Li
Time: 12:46pm
Grand Ballroom C620: HBI-8000, a class I histone deacetylase (HDAC) inhibitor, in combination with nivolumab for treatment of anti-PD(L)1-naive advanced melanoma: final analysis of Study HBI-8000-302
Listed as Top 100 abstract
Oral
Nikhil Khushalani
Time: 3:44pm
Grand Ballroom B368: Translational analyses reveal mechanisms of afami-cel’s anti-tumor activity in synovial sarcoma
Listed as Top 100 abstract
Oral Presentation
Mihaela Druta
Time: 4:39pm
Grand Ballroom B